StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Big one back on the ask this am

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Apr 01, 2024 10:48am

51 Views

Post# 35962777

RE:RE:Big one back on the ask this am

WillHey wrote: This is the second time I have seen this. Cant remember if the first comment was from you are not but can someone explain why a large ask at 6 cents or anything low like that would be considered a good sign?

Pretty much deflection, kind of like an institution "gobbling" up shares. Squirrel, squirrel.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing